ArticleFrontiers in immunology2020

HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model.

Kamira Maharaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.